Kamada (KMDA) Equity Income (2018 - 2019)
Kamada (KMDA) posted quarterly Equity Income of $55000.0 for Q3 2019, up 222.22% year-on-year from $17069.0 in Q3 2018, and up 311.54% on a QoQ basis from -$26000.0 in Q4 2018.
Kamada (KMDA) Equity Income (2018 - 2019) Analysis & Trends
Kamada (KMDA) has reported Equity Income for 2 consecutive years, with $55000.0 the latest figure, recorded in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 55,000.00 |
| Dec 31, 2018 | -26,000.00 |
| Sep 30, 2018 | -45,000.00 |